Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
Date
2022-06-02
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Hager, K J, Pérez Marc, G, Gobeil, P, Diaz, R S, Heizer, G, Llapur, C, Makarkov, A I, Vasconcellos, E, Pillet, S, Riera, F, Saxena, P, Geller Wolff, P, Bhutada, K, Wallace, G, Aazami, H, Jones, C E, Polack, F P, Ferrara, L, Atkins, J, Boulay, I, Dhaliwall, J, Charland, N, Couture, M M J, Jiang-Wright, J, Landry, N, Lapointe, S, Lorin, A, Mahmood, A, Moulton, L H, Pahmer, E, Parent, J, Séguin, A, Tran, L, Breuer, T, Ceregido, M-A, Koutsoukos, M, Roman, F, Namba, J, D'Aoust, M-A, Trepanier, S, Kimura, Y, Ward, B J & CoVLP Study Team 2022, 'Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine', The New England Journal of Medicine, vol. 386, 2201300, pp. 2084-2096. https://doi.org/10.1056/NEJMoa2201300